About Open Orphan
Open Orphan is a company based in London (United Kingdom) founded in 2017.. The company has 218 employees as of January 31, 2021. Open Orphan has completed 1 acquisition, including CHIMagents. Open Orphan offers products and services including Human Challenge Trials and Laboratory Services. Open Orphan operates in a competitive market with competitors including Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others.
- Headquarter London, United Kingdom
- Employees 218 as on 31 Jan, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Open Orphan Plc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$14.66 M (USD), Post-IPO
May 22, 2020
-
Investors
-
Employee Count
218
as on Jan 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Open Orphan
Open Orphan offers a comprehensive portfolio of products and services, including Human Challenge Trials and Laboratory Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts controlled trials for testing vaccines against infectious diseases.
Provides analytical support for clinical research and drug development.
Funding Insights of Open Orphan
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $14.7M
-
First Round
First Round
(31 Jan 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Post-IPO - Open Orphan | Valuation |
investors |
|
| Jan, 2020 | Amount | Post-IPO - Open Orphan | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Open Orphan
Open Orphan has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CHIMagents. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Potential antiviral drugs and vaccines are manufactured for testing.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Open Orphan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Open Orphan Comparisons
Competitors of Open Orphan
Open Orphan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altasciences, Ask Gene Pharma, Celerion, MindBio Therapeutics and iCardiac Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Early phase clinical research services are provided in North America.
|
|
| domain | founded_year | HQ Location |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| domain | founded_year | HQ Location |
Early clinical research services are provided for drug development.
|
|
| domain | founded_year | HQ Location |
Provider of phase I & II clinical trial services for mental health diseases
|
|
| domain | founded_year | HQ Location |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| domain | founded_year | HQ Location |
Clinical development services are provided to pharmaceutical clients worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Open Orphan
Frequently Asked Questions about Open Orphan
When was Open Orphan founded?
Open Orphan was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Open Orphan located?
Open Orphan is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
How many employees does Open Orphan have?
As of Jan 31, 2021, the latest employee count at Open Orphan is 218.
What does Open Orphan do?
Open Orphan was founded in 2017 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, where vaccines and antivirals are tested through controlled human challenge studies and clinical trials. Services extend to infectious and respiratory disease research, as well as laboratory support. Contract research organization functions are handled for pharmaceutical clients, supporting drug development processes.
Who are the top competitors of Open Orphan?
Open Orphan's top competitors include Celerion, Ask Gene Pharma and Altasciences.
What products or services does Open Orphan offer?
Open Orphan offers Human Challenge Trials and Laboratory Services.
How many acquisitions has Open Orphan made?
Open Orphan has made 1 acquisition, including CHIMagents.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.